Developer docs
API playgroundTry for free, no card

Search company profiles

VirexpR

Full company profile

uuid0099gxa

Namestring
VirexpR
Legal namestring
VIREXPR SAS
Websiteurl
virexpr.fr
Company typeenum
Private
Founded yearint
2022
Descriptiontext

VirexpR SAS is a French private consulting and laboratory services company founded in 2022 in the Lyon metropolitan area, specializing in microbiology and virology applied to indoor air quality. The firm originated from over a decade of applied virology research conducted at the VirPath laboratory and Virnext platform within CIRI (INSERM, CNRS, Université Claude Bernard Lyon 1, ENS de Lyon), and was established by Dr. Manuel Rosa-Calatrava, Thomas Julien, and Anaïs Proust. It operates from Reyrieux (Ain) near Lyon with R&D presence in Lyon and Grenoble, and established a North American subsidiary in Quebec in 2025.

The company's core offering is an integrated four-pillar service chain: (1) in-situ microbiological diagnostics (air, surface, and bio-process sampling with TCID50, PFU, PCR/qPCR, ELISA, and hemagglutination assays); (2) experimental testing in BSL-2 and BSL-3 laboratories using test chambers of 2.5m³, 20m³, and 30m³ plus a One-Pass bench compliant with ISO 15714:2019 (up to 2,000 m³/h); (3) Computational Fluid Dynamics (CFD) numerical simulation using ANSYS Fluent and SpaceClaim; and (4) solution deployment and training. It also performs standards-based device evaluation under IEC PAS 63086, ASHRAE 185.3, and ISO 15714:2019, and conducts research under two flagship programs: GESPPAIR (a €3.5M France 2030-laureate program led by VirexpR) and VIRCATCHER (a CEA-Leti co-development for indoor-air respiratory pathogen detection).

VirexpR runs a sales-led, enterprise B2B go-to-market, engaging directly with air treatment device manufacturers, hospitals and EHPADs, pharmaceutical and cleanroom operators, public transport providers (e.g., ALSTOM), agricultural and livestock operators (e.g., Calistair deployed at Orvia Group), engineering consultancies, and research institutions (e.g., CEA-Leti, Bertin Technologies, ERLAB). Revenue is generated through project-based professional services engagements, standards-based testing and certification, and non-dilutive public R&D funding (France 2030, Région Auvergne-Rhône-Alpes, Bpifrance), supplemented by equity capital from Groupe TERA which entered shortly after the 2022 founding.

Short descriptiontext

VirexpR is a French B2B consulting and laboratory services firm that evaluates and deploys air treatment technologies against airborne infectious pathogens, using BSL-3 test chambers, CFD simulation, and standards-based testing for enterprise clients in healthcare, transport, pharmaceuticals, and agriculture.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersReyrieux, France
HQ citystring
Reyrieux
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
airborne infection control, indoor air quality, BSL-3 testing services, virology consulting services, CFD air simulation
Industry4 codes
PRIMARYAFALAEAD
Air & Aerosol Monitoring (Bioaerosols, Mold, Yeast, Airborne Pathogens)
Agriculture & Food Production/Food Safety, Testing & Certification/Environmental Monitoring & Hygiene Verification (Swabs, ATP, Pathogen Monitoring)
SECONDARYBPABAGAI
Indoor Air Quality (IAQ) Monitoring & Ventilation Optimization
Business & Public Services/Facilities Management & Building Services/Building Automation, Energy Management & Smart Building Services
SECONDARYHSAOAIAD
Indoor Air Quality (IAQ) Testing & Monitoring
Home & Personal Services/Plumbing, Electrical & HVAC Services/Air Duct Cleaning, Ventilation & Indoor Air Quality Services
SECONDARYHLAHANAK
Air Quality & Environmental Infection Control (HEPA Filtration, Isolation Barriers, CSSD/HVAC Solutions)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
NAICS code2 codes
  • Medical Laboratories621511
  • Testing Laboratories and Services541380
SIC code2 codes
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
Product category
Air Quality Testing & Consulting Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Consulting and advisory services
TypeProfessional Services
Description

VirexpR provides expert consulting and advisory services in microbiology and virology applied to indoor air quality. Services include in-situ diagnostics, experimental bench testing, numerical simulation, and deployment optimization of air purification technologies. Revenue is generated through project-based professional service engagements with enterprise clients.

virexpr.fr
2Testing and certification services
TypeProfessional Services
Description

Performance evaluation of air treatment devices according to international standards (IEC PAS 63086, ASHRAE 185.3, ISO 15714:2019) in BSL-3 environments, generating revenue from device manufacturers and industrial clients seeking certification and comparative performance data.

virexpr.fr
3R&D partnerships and public funding
TypeManaged Services
Description

Revenue partially derived from public R&D funding programs including France 2030 (GESPPAIR: €2.24M subsidy), Region Auvergne-Rhône-Alpes (VIRCATCHER), and Bpifrance support, representing non-dilutive funding for collaborative development projects.

virexpr.fr
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1VIRCATCHER
Description

R&D program for respiratory pathogen detection and measurement device development in collaboration with CEA-Leti

virexpr.fr
+1 more record
Core offering1 text field

VirexpR provides consulting and technical services in microbiology and virology applied to indoor air quality. The offering combines four interconnected service pillars: (1) in-situ diagnostic sampling and pathogen detection, (2) experimental evaluation of air treatment devices in BSL-2/BSL-3 test chambers (2.5m³ to 30m³ and One-Pass), (3) CFD numerical simulation for airflow characterization, and (4) deployment optimization of air purification technologies. Services are sold to enterprise and institutional clients under international standards (IEC PAS 63086, ASHRAE 185.3, ISO 15714:2019).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • ERLAB pharmaceutical technical zone achieved ISO-7 classification after VirexpR CFD-guided deployment optimization of Halo 35® air filtration system
+3 more records
Product overview1 text field

VirexpR offers an integrated service portfolio focused on airborne infectious contamination control. The core offering combines four interconnected service pillars: (1) Diagnostic services for in-situ sampling and pathogen detection, (2) Experimental testing using specialized test chambers (2.5m³, 20m³, 30m³, One Pass) in BSL-2/BSL-3 environments, (3) Numerical simulation using CFD modeling for airflow characterization and optimization, and (4) Solution deployment with custom air purification technology implementation and training. Two major R&D programs extend the portfolio: GESPPAIR (France 2030-funded collaborative program for contamination management) and VIRCATCHER (joint program with CEA-Leti for respiratory pathogen detection). The company also provides standards-based evaluation services per IEC PAS 63086, ASHRAE 185.3, and ISO 15714:2019 for device certification.

Product and service5 records
1Diagnostic Services
CategoryCore Service - In-situ Diagnostics
Description

In-situ sampling services for detecting, identifying, and quantifying airborne pathogens in confined environments. Includes air sampling, surface sampling, and bio-process sampling, with analysis capabilities for infectious viruses (TCID50, PFU), genomes (PCR, qPCR, sequencing), other pathogens, and proteins (ELISA, hemagglutination, SRID). Sold to enterprise and institutional clients needing pathogen characterization in healthcare, pharmaceutical, transport, and agricultural settings.

2Experimental Testing Services
CategoryCore Service - Laboratory Testing
Description

Testing services using 2.5m³, 20m³, and 30m³ test chambers plus an ISO 15714:2019 One-Pass test bench for evaluating air treatment and analysis devices in BSL-2 and BSL-3 environments against pathogens including SARS-CoV-2, influenza viruses, coronaviruses, adenoviruses, and RSV. Sold to device manufacturers and industrial clients for performance evaluation.

3Numerical Simulation Services
CategoryCore Service - CFD Simulation
Description

Computational Fluid Dynamics (CFD) modeling and simulation services using ANSYS SpaceClaim and ANSYS Fluent to characterize airflow patterns, guide experimental positioning, generate realistic contamination scenarios, and optimize air treatment device deployment in real environments. Sold to enterprise clients for air quality modeling and solution optimization.

4Solution Deployment Services
CategoryCore Service - Deployment & Training
Description

Custom solutions for air treatment deployment including environment-specific measurements, experimental guidance, device positioning optimization, and training services for sustainable and effective use of air treatment devices. Sold to enterprise and institutional clients seeking turnkey deployment of validated air treatment technologies.

5Standards Evaluation Services
CategoryCore Service - Standards & Certification Testing
Description

Testing and certification services for air treatment devices according to international standards including IEC PAS 63086, ASHRAE 185.3, and ISO 15714:2019. Evaluates device performance against various microorganisms (viruses, bacteria, molds) for air purification effectiveness. Sold to device manufacturers seeking regulatory compliance and certification evidence.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Strategic R&D collaboration between VirexpR (Lyon) and CEA-Leti (Grenoble) under the Region Auvergne-Rhône-Alpes Innovation Partnerships program. Jointly developing the VIRCATCHER device for detecting and measuring respiratory pathogens in indoor air, based on CEA-Leti's ARISE microtechnology. Aligned with Innovation Santé 2023 plan and contributes to national and European sovereignty in protection against emerging infectious diseases.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

IMeBIO is a partner in the GESPPAIR collaborative R&D program (France 2030). In 2025, IMeBIO and VirexpR deployed the IMEPod modular BSL-3 laboratory for expanded high-containment testing capabilities.

3VirPath / CIRI (INSERM, CNRS, UCBL1, ENS Lyon)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

VirexpR originated from over 10 years of applied research at the VirPath laboratory and its virnext technology platform within the Centre International de Recherche en Infectiologie (CIRI). VirPath and virnext remain academic partners in the GESPPAIR program, contributing virology expertise and BSL-3 research infrastructure.

virexpr.fr
Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Industrial partner in the GESPPAIR collaborative R&D program, contributing to the development of an ambitious technology offering for airborne pathogen management in confined environments.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Auvergne-Rhône-Alpes competitiveness cluster that has labelled the GESPPAIR program. Provides cluster support and networking within the regional innovation ecosystem.

6Lyonbiopôle Auvergne-Rhône-Alpes
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Auvergne-Rhône-Alpes competitiveness cluster (health sector) that has labelled the GESPPAIR program, providing cluster support and ecosystem integration for VirexpR within the regional health innovation landscape.

virexpr.fr
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

LYON INGENIERIE PROJETS, a subsidiary of Université Claude Bernard Lyon 1, provides program accompaniment for the GESPPAIR collaborative R&D initiative.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

U.S. IAQ testing laboratory offering microbiological, bioaerosol and air-quality analytical services. Direct comparable on indoor pathogen testing with overlapping use cases (mold, bacteria, allergen and viral panels).

TypeDirect peer
Description

North American specialized laboratory focused on bioaerosol and microbiological IAQ testing (mold, bacteria, viruses). Direct peer to VirexpR on diagnostic sampling and analysis of airborne pathogens in confined environments.

TypeRegional player
Description

French occupational health and safety research body with exposure assessment capability relevant to airborne contaminants. Comparable on French workplace-IAQ expertise, though not a commercial competitor.

TypeBroad incumbent
Description

International testing services network with environmental/IAQ and microbiological testing capabilities. Overlaps with VirexpR on standards-based IAQ testing for industrial clients, at broader scale.

5BIOASTER
TypeDirect peer
Description

French non-profit applied microbiology research technology institute based in Lyon. Closely comparable on applied microbiology/virology methodology and overlapping scientific ecosystem with VirPath/CIRI.

TypeOthers
Description

French instrumentation supplier (including Coriolis bio-collectors) and VirexpR customer/partner. Adjacent rather than directly competitive — they manufacture bio-collection devices VirexpR tests.

7ICARE Environnement / ICARE LAB
TypeEmerging player
Description

French specialized IAQ testing and consulting firm focused on microbiological and chemical indoor-air diagnostics. Closest France-based specialised peer in scope (diagnostic sampling and microbial IAQ testing) though at smaller scale and without BSL-3 capabilities.

TypeBroad incumbent
Description

Global leader in testing/certification with established IAQ, environmental microbiology and biocontaminant assay services. Vastly larger scale and sales reach, but only partially overlaps with VirexpR's BSL-3 viral-aerosol specialization.

TypeBroad incumbent
Description

Global testing, inspection and certification incumbent with industrial hygiene and air-quality service lines. Comparable business model and target OEMs, but broader portfolio and not specialized in BSL-3 viral aerosol evaluation.

TypeBroad incumbent
Description

International testing and certification group serving industrial clients with HSE/IAQ assessment services. Overlaps on standards-based performance evaluation for air treatment devices but at much greater breadth and lesser viral specialization.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VirexpR

Air Quality Testing & Consulting Servicesvirexpr.fr

VirexpR is a French B2B consulting and laboratory services firm that evaluates and deploys air treatment technologies against airborne infectious pathogens, using BSL-3 test chambers, CFD simulation, and standards-based testing for enterprise clients in healthcare, transport, pharmaceuticals, and agriculture.

What VirexpR does

VirexpR SAS is a French private consulting and laboratory services company founded in 2022 in the Lyon metropolitan area, specializing in microbiology and virology applied to indoor air quality. The firm originated from over a decade of applied virology research conducted at the VirPath laboratory and Virnext platform within CIRI (INSERM, CNRS, Université Claude Bernard Lyon 1, ENS de Lyon), and was established by Dr. Manuel Rosa-Calatrava, Thomas Julien, and Anaïs Proust. It operates from Reyrieux (Ain) near Lyon with R&D presence in Lyon and Grenoble, and established a North American subsidiary in Quebec in 2025.

The company's core offering is an integrated four-pillar service chain: (1) in-situ microbiological diagnostics (air, surface, and bio-process sampling with TCID50, PFU, PCR/qPCR, ELISA, and hemagglutination assays); (2) experimental testing in BSL-2 and BSL-3 laboratories using test chambers of 2.5m³, 20m³, and 30m³ plus a One-Pass bench compliant with ISO 15714:2019 (up to 2,000 m³/h); (3) Computational Fluid Dynamics (CFD) numerical simulation using ANSYS Fluent and SpaceClaim; and (4) solution deployment and training. It also performs standards-based device evaluation under IEC PAS 63086, ASHRAE 185.3, and ISO 15714:2019, and conducts research under two flagship programs: GESPPAIR (a €3.5M France 2030-laureate program led by VirexpR) and VIRCATCHER (a CEA-Leti co-development for indoor-air respiratory pathogen detection).

VirexpR runs a sales-led, enterprise B2B go-to-market, engaging directly with air treatment device manufacturers, hospitals and EHPADs, pharmaceutical and cleanroom operators, public transport providers (e.g., ALSTOM), agricultural and livestock operators (e.g., Calistair deployed at Orvia Group), engineering consultancies, and research institutions (e.g., CEA-Leti, Bertin Technologies, ERLAB). Revenue is generated through project-based professional services engagements, standards-based testing and certification, and non-dilutive public R&D funding (France 2030, Région Auvergne-Rhône-Alpes, Bpifrance), supplemented by equity capital from Groupe TERA which entered shortly after the 2022 founding.

VirexpR firmographics

Firmographics
Name
VirexpR
Legal name
VIREXPR SAS
Website
https://virexpr.fr
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
VirexpR is a French B2B consulting and laboratory services firm that evaluates and deploys air treatment technologies against airborne infectious pathogens, using BSL-3 test chambers, CFD simulation, and standards-based testing for enterprise clients in healthcare, transport, pharmaceuticals, and agriculture.
Ownership category
akta.pro rank

VirexpR industry classification

Industry
Product category
Air Quality Testing & Consulting Services
NAICS
Medical Laboratories (621511), Testing Laboratories and Services (541380)
SIC
Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYAFALAEAD
Air & Aerosol Monitoring (Bioaerosols, Mold, Yeast, Airborne Pathogens)
Agriculture & Food Production/Food Safety, Testing & Certification/Environmental Monitoring & Hygiene Verification (Swabs, ATP, Pathogen Monitoring)
SECONDARYBPABAGAI
Indoor Air Quality (IAQ) Monitoring & Ventilation Optimization
Business & Public Services/Facilities Management & Building Services/Building Automation, Energy Management & Smart Building Services
SECONDARYHSAOAIAD
Indoor Air Quality (IAQ) Testing & Monitoring
Home & Personal Services/Plumbing, Electrical & HVAC Services/Air Duct Cleaning, Ventilation & Indoor Air Quality Services
SECONDARYHLAHANAK
Air Quality & Environmental Infection Control (HEPA Filtration, Isolation Barriers, CSSD/HVAC Solutions)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables

Keywords

  • Airborne infection control
  • Indoor air quality
  • BSL-3 testing services
  • Virology consulting services
  • CFD air simulation

Where VirexpR is headquartered

Location

Headquarters

HQ city
Reyrieux
HQ country
France
HQ region
Europe

Offices4 records

Markets served

VirexpR business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Consulting and advisory services: VirexpR provides expert consulting and advisory services in microbiology and virology applied to indoor air quality. Services include in-situ diagnostics, experimental bench testing, numerical simulation, and deployment optimization of air purification technologies. Revenue is generated through project-based professional service engagements with enterprise clients.
  2. Testing and certification services: Performance evaluation of air treatment devices according to international standards (IEC PAS 63086, ASHRAE 185.3, ISO 15714:2019) in BSL-3 environments, generating revenue from device manufacturers and industrial clients seeking certification and comparative performance data.
  3. R&D partnerships and public funding: Revenue partially derived from public R&D funding programs including France 2030 (GESPPAIR: €2.24M subsidy), Region Auvergne-Rhône-Alpes (VIRCATCHER), and Bpifrance support, representing non-dilutive funding for collaborative development projects.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

VirexpR product offering

Product offering

Core offering

VirexpR provides consulting and technical services in microbiology and virology applied to indoor air quality. The offering combines four interconnected service pillars: (1) in-situ diagnostic sampling and pathogen detection, (2) experimental evaluation of air treatment devices in BSL-2/BSL-3 test chambers (2.5m³ to 30m³ and One-Pass), (3) CFD numerical simulation for airflow characterization, and (4) deployment optimization of air purification technologies. Services are sold to enterprise and institutional clients under international standards (IEC PAS 63086, ASHRAE 185.3, ISO 15714:2019).

Product overview

VirexpR offers an integrated service portfolio focused on airborne infectious contamination control. The core offering combines four interconnected service pillars: (1) Diagnostic services for in-situ sampling and pathogen detection, (2) Experimental testing using specialized test chambers (2.5m³, 20m³, 30m³, One Pass) in BSL-2/BSL-3 environments, (3) Numerical simulation using CFD modeling for airflow characterization and optimization, and (4) Solution deployment with custom air purification technology implementation and training. Two major R&D programs extend the portfolio: GESPPAIR (France 2030-funded collaborative program for contamination management) and VIRCATCHER (joint program with CEA-Leti for respiratory pathogen detection). The company also provides standards-based evaluation services per IEC PAS 63086, ASHRAE 185.3, and ISO 15714:2019 for device certification.

Differentiator

Problem solved

Functional benefit

Brands

  • VIRCATCHER: R&D program for respiratory pathogen detection and measurement device development in collaboration with CEA-Leti
  • GESPPAIR

Products and services

  • Diagnostic Services In-situ sampling services for detecting, identifying, and quantifying airborne pathogens in confined environments. Includes air sampling, surface sampling, and bio-process sampling, with analysis capabilities for infectious viruses (TCID50, PFU), genomes (PCR, qPCR, sequencing), other pathogens, and proteins (ELISA, hemagglutination, SRID). Sold to enterprise and institutional clients needing pathogen characterization in healthcare, pharmaceutical, transport, and agricultural settings.
  • Experimental Testing Services Testing services using 2.5m³, 20m³, and 30m³ test chambers plus an ISO 15714:2019 One-Pass test bench for evaluating air treatment and analysis devices in BSL-2 and BSL-3 environments against pathogens including SARS-CoV-2, influenza viruses, coronaviruses, adenoviruses, and RSV. Sold to device manufacturers and industrial clients for performance evaluation.
  • Numerical Simulation Services Computational Fluid Dynamics (CFD) modeling and simulation services using ANSYS SpaceClaim and ANSYS Fluent to characterize airflow patterns, guide experimental positioning, generate realistic contamination scenarios, and optimize air treatment device deployment in real environments. Sold to enterprise clients for air quality modeling and solution optimization.
  • Solution Deployment Services Custom solutions for air treatment deployment including environment-specific measurements, experimental guidance, device positioning optimization, and training services for sustainable and effective use of air treatment devices. Sold to enterprise and institutional clients seeking turnkey deployment of validated air treatment technologies.
  • Standards Evaluation Services Testing and certification services for air treatment devices according to international standards including IEC PAS 63086, ASHRAE 185.3, and ISO 15714:2019. Evaluates device performance against various microorganisms (viruses, bacteria, molds) for air purification effectiveness. Sold to device manufacturers seeking regulatory compliance and certification evidence.

Quantifiable outcome

  • ERLAB pharmaceutical technical zone achieved ISO-7 classification after VirexpR CFD-guided deployment optimization of Halo 35® air filtration system
  • +3 more outcomes

Companies that use VirexpR

Customer profile

Named customers5 records

Segments6 records

Ideal customer profiles6 records

VirexpR technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

VirexpR partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core, secondary and supporting.

  • CEA-LeticoreStrategic or Co-development Partner · 1 January 2023Strategic R&D collaboration between VirexpR (Lyon) and CEA-Leti (Grenoble) under the Region Auvergne-Rhône-Alpes Innovation Partnerships program. Jointly developing the VIRCATCHER device for detecting and measuring respiratory pathogens in indoor air, based on CEA-Leti's ARISE microtechnology. Aligned with Innovation Santé 2023 plan and contributes to national and European sovereignty in protection against emerging infectious diseases.
  • IMeBIOcoreStrategic or Co-development PartnerIMeBIO is a partner in the GESPPAIR collaborative R&D program (France 2030). In 2025, IMeBIO and VirexpR deployed the IMEPod modular BSL-3 laboratory for expanded high-containment testing capabilities.
  • VirPath / CIRI (INSERM, CNRS, UCBL1, ENS Lyon)coreStrategic or Co-development PartnerVirexpR originated from over 10 years of applied research at the VirPath laboratory and its virnext technology platform within the Centre International de Recherche en Infectiologie (CIRI). VirPath and virnext remain academic partners in the GESPPAIR program, contributing virology expertise and BSL-3 research infrastructure.
  • CONIDIA CONIPHYsecondaryStrategic or Co-development PartnerIndustrial partner in the GESPPAIR collaborative R&D program, contributing to the development of an ambitious technology offering for airborne pathogen management in confined environments.
  • AXELERAsupportingStrategic or Co-development PartnerAuvergne-Rhône-Alpes competitiveness cluster that has labelled the GESPPAIR program. Provides cluster support and networking within the regional innovation ecosystem.
  • Lyonbiopôle Auvergne-Rhône-AlpessupportingStrategic or Co-development PartnerAuvergne-Rhône-Alpes competitiveness cluster (health sector) that has labelled the GESPPAIR program, providing cluster support and ecosystem integration for VirexpR within the regional health innovation landscape.
  • Lyon Ingenierie Projets (Université Claude Bernard Lyon 1)supportingStrategic or Co-development PartnerLYON INGENIERIE PROJETS, a subsidiary of Université Claude Bernard Lyon 1, provides program accompaniment for the GESPPAIR collaborative R&D initiative.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

VirexpR competitors and assessment

Company assessment

Direct peers

  • EMSL Analytical: U.S. IAQ testing laboratory offering microbiological, bioaerosol and air-quality analytical services. Direct comparable on indoor pathogen testing with overlapping use cases (mold, bacteria, allergen and viral panels).
  • Aerobiology Laboratory Associates: North American specialized laboratory focused on bioaerosol and microbiological IAQ testing (mold, bacteria, viruses). Direct peer to VirexpR on diagnostic sampling and analysis of airborne pathogens in confined environments.
  • BIOASTER: French non-profit applied microbiology research technology institute based in Lyon. Closely comparable on applied microbiology/virology methodology and overlapping scientific ecosystem with VirPath/CIRI.

Regional players

Broad incumbents

  • ALS Global: International testing services network with environmental/IAQ and microbiological testing capabilities. Overlaps with VirexpR on standards-based IAQ testing for industrial clients, at broader scale.
  • Eurofins Scientific: Global leader in testing/certification with established IAQ, environmental microbiology and biocontaminant assay services. Vastly larger scale and sales reach, but only partially overlaps with VirexpR's BSL-3 viral-aerosol specialization.
  • SGS: Global testing, inspection and certification incumbent with industrial hygiene and air-quality service lines. Comparable business model and target OEMs, but broader portfolio and not specialized in BSL-3 viral aerosol evaluation.
  • Bureau Veritas: International testing and certification group serving industrial clients with HSE/IAQ assessment services. Overlaps on standards-based performance evaluation for air treatment devices but at much greater breadth and lesser viral specialization.

Others

  • Bertin Technologies: French instrumentation supplier (including Coriolis bio-collectors) and VirexpR customer/partner. Adjacent rather than directly competitive — they manufacture bio-collection devices VirexpR tests.

Emerging players

  • ICARE Environnement / ICARE LAB: French specialized IAQ testing and consulting firm focused on microbiological and chemical indoor-air diagnostics. Closest France-based specialised peer in scope (diagnostic sampling and microbial IAQ testing) though at smaller scale and without BSL-3 capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

VirexpR social profiles

Digital presence

VirexpR financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VirexpR leadership team

Management profile

Number of profiles

Profiles10 records

VirexpR subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

VirexpR funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VirexpR M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VirexpR

What does VirexpR do?

VirexpR provides consulting and technical services in microbiology and virology applied to indoor air quality. The offering combines four interconnected service pillars: (1) in-situ diagnostic sampling and pathogen detection, (2) experimental evaluation of air treatment devices in BSL-2/BSL-3 test chambers (2.5m³ to 30m³ and One-Pass), (3) CFD numerical simulation for airflow characterization, and (4) deployment optimization of air purification technologies. Services are sold to enterprise and institutional clients under international standards (IEC PAS 63086, ASHRAE 185.3, ISO 15714:2019).

Is VirexpR a public or private company?

VirexpR is a private company. It is classified as venture growth investor backed and is currently operating.

When was VirexpR founded?

VirexpR was founded in 2022. It employs 1 to 10 people.

Where is VirexpR based?

VirexpR is headquartered in Reyrieux, France, in the Europe region.

How does VirexpR make money?

Three revenue lines are on record. Consulting and advisory services are the primary driver. The others are testing and certification services and R&D partnerships and public funding.

Who are VirexpR's main competitors?

Direct peers on record are EMSL Analytical, Aerobiology Laboratory Associates and BIOASTER. INRS (Institut National de Recherche et de Sécurité) is listed as a regional player. Broad incumbents are ALS Global, Eurofins Scientific, SGS and Bureau Veritas. Bertin Technologies is listed as an others. ICARE Environnement / ICARE LAB is listed as an emerging player.

Does VirexpR have an API?

No public API is recorded for VirexpR.

What industry is VirexpR in?

VirexpR's product category is Air Quality Testing & Consulting Services. Its primary akta.pro industry code is AFALAEAD, Air & Aerosol Monitoring (Bioaerosols, Mold, Yeast, Airborne Pathogens), with a secondary code of BPABAGAI, Indoor Air Quality (IAQ) Monitoring & Ventilation Optimization. Its NAICS code is 621511 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales